Viewing Study NCT05033106


Ignite Creation Date: 2025-12-26 @ 1:18 PM
Ignite Modification Date: 2026-01-01 @ 2:05 AM
Study NCT ID: NCT05033106
Status: UNKNOWN
Last Update Posted: 2021-09-02
First Post: 2021-08-26
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Ranibizumab Vs Bevacizumab for Type 1 Retinopathy of Prematurity
Sponsor: Zagazig University
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module